Atossa Therapeutics, Inc.
ATOS · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | August 13, 2026 | — | — | — | -1.04 | — |
| 2026 Q1 | May 8, 2026 | — | — | -1.11 | -1.22 | 0.00% |
| 2025 Q4 | March 25, 2026 | — | — | -1.19 | -1.05 | -1.63% |
| 2025 Q3 | November 12, 2025 | — | — | -15.75 | -1.05 | -1.74% |
| 2025 Q2 | August 12, 2025 | — | — | -1.05 | -0.90 | +1.24% |
| 2025 Q1 | May 12, 2025 | — | — | -0.75 | -0.82 | +6.34% |
| 2024 Q4 | March 25, 2025 | — | — | -0.75 | -0.90 | -3.30% |
| 2024 Q3 | November 12, 2024 | — | — | -0.75 | -0.82 | -7.41% |
| 2024 Q2 | August 12, 2024 | — | — | -0.75 | -0.75 | +4.84% |
| 2024 Q1 | May 13, 2024 | — | — | -0.05 | -0.07 | — |
| 2023 Q4 | April 1, 2024 | 18.00K | — | -0.90 | -0.75 | +3.70% |
| 2023 Q3 | November 13, 2023 | — | — | -0.75 | -0.07 | -0.60% |
| 2023 Q2 | August 14, 2023 | — | — | -0.90 | -0.06 | -8.29% |
| 2023 Q1 | May 15, 2023 | — | — | -0.05 | -0.06 | +0.81% |
| 2022 Q4 | March 22, 2023 | — | — | -0.06 | -0.06 | +3.76% |
| 2022 Q2 | August 8, 2022 | — | — | -0.05 | -0.06 | +5.56% |